US Opening Bell | Dow edges higher, Nasdaq flat; Dell jumps 10% on outlook; Chinese ADRs rally

US Opening Bell
Yesterday

Market

September 2, U.S. stocks opened mixed: the Dow Jones rose 0.35%, the S&P 500 inched up 0.08%, while the Nasdaq Composite slipped 0.02%. Traders balanced a flood of upbeat corporate results against fresh Federal Reserve signals that rate cuts remain on hold, leaving overall sentiment cautiously optimistic.

Viomi Technology Co. surged 31.02% after its founder proposed a $200 million go-private deal. Universe Pharmaceuticals Inc. jumped 22.25% on FDA clearance for a Phase III trial of its flu remedy. GitLab, Inc. rallied 15.06% as the developer-tools firm raised full-year revenue guidance. Dell Technologies Inc. climbed 10.34% on record quarterly sales and strong AI-server demand. Eos Energy Enterprises Inc. advanced 7.57% following a $300 million Department of Energy loan commitment, while Zai Lab Ltd added 5.36% on positive oncology data. On the downside, Yatsen Holding Limited slumped 10.90% after soft beauty-product sales, and Canaan Inc. sank 8.19% as falling bitcoin prices hit mining-rig orders.

Among widely held names, Apple gained 0.79% ahead of next week’s iPhone launch, NVIDIA edged up 1.20% to extend its AI-chip rally, and Tesla Motors rose 0.17% on fresh battery-cost targets. SPDR Gold ETF added 0.72% as bullion stayed firm. Marvell Technology fell 1.76% on cautious margin guidance, while Palantir Technologies Inc. slid 2.77% amid profit-taking.

News

Dell Technologies Inc. beats expectations and lifts guidance, shares leap 10%. Record AI-server demand powered a revenue surge and a better-than-forecast outlook, boosting sentiment across hardware peers.

GitLab, Inc. raises full-year revenue forecast, stock rallies 15%. The DevOps platform cited strong enterprise adoption and accelerating subscription growth, easing concerns about slowing tech spending.

Universe Pharmaceuticals Inc. secures FDA Phase III green light, jumps 22%. The nod for its traditional Chinese medicine flu candidate paves the way for late-stage trials in the U.S. and potential partnerships.

Viomi Technology Co. receives $200 million go-private bid, soars 31%. The Chinese smart-home appliance maker said its founder group offered a 60% premium to acquire outstanding shares.

Eos Energy Enterprises Inc. wins conditional $300 million DOE loan, rises 8%. Funds will support construction of a large-scale zinc battery plant, bolstering the company’s long-duration storage ambitions.

Federal Reserve leaves rates unchanged, vows data-driven approach. Policymakers signaled they need more evidence of cooling inflation before considering cuts, tempering expectations for early 2027 easing.

Apple sets September event for iPhone 18 unveiling, stock up modestly. Invitations tease AI-infused features, keeping investors focused on the company’s push into generative services.

NIO Inc. cuts prices on new EV lineup, shares fall 3%. The move aims to defend market share in China’s intensifying electric-vehicle price war but raises margin concerns.

Canaan Inc. issues revenue warning amid crypto slowdown, drops 8%. Management cited weaker Bitcoin mining demand and delayed ASIC orders, prompting analysts to trim forecasts.

Yatsen Holding Limited reports soft Q2 cosmetics sales, sinks 11%. The company flagged slower consumer spending and higher marketing costs, stoking worries about profitability.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10